<VariationArchive VariationID="7185" VariationName="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs)" VariationType="Duplication" Accession="VCV000007185" Version="45" RecordType="classified" NumberOfSubmissions="17" NumberOfSubmitters="16" DateLastUpdated="2024-07-29" DateCreated="2017-12-12" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22224" VariationID="7185">
      <GeneList>
        <Gene Symbol="CFTR" FullName="CF transmembrane conductance regulator" GeneID="1080" HGNC_ID="HGNC:1884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117480025" stop="117668665" display_start="117480025" display_stop="117668665" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117120016" stop="117308718" display_start="117120016" display_stop="117308718" Strand="+" />
          </Location>
          <OMIM>602421</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs)</Name>
      <CanonicalSPDI>NC_000007.14:117592340:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117592340" stop="117592341" display_start="117592340" display_stop="117592341" variantLength="1" positionVCF="117592340" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117232394" stop="117232395" display_start="117232394" display_stop="117232395" variantLength="1" positionVCF="117232394" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <OtherNameList>
        <Name>2307insA</Name>
      </OtherNameList>
      <ProteinChange>E726fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.117232396dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.117232396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.117592342dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.117592342dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.131559dup">
            <Expression>NG_016465.4:g.131559dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.2175dup" MANESelect="true">
            <Expression>NM_000492.4:c.2175dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000483.3" sequenceAccession="NP_000483" sequenceVersion="3" change="p.Glu726fs">
            <Expression>NP_000483.3:p.Glu726fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_663" sequenceAccession="LRG_663">
            <Expression>LRG_663:g.131559dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_663t1" sequenceAccession="LRG_663t1">
            <Expression>LRG_663t1:c.2175dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_663p1" sequenceAccession="LRG_663p1" change="p.Glu726fs">
            <Expression>LRG_663p1:p.Glu726fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.2175dupA">
            <Expression>NM_000492.3:c.2175dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="GTR000576392" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="602421.0081" DB="OMIM" />
        <XRef Type="rs" ID="746418935" DB="dbSNP" />
        <XRef ID="CA325575" DB="ClinGen" />
        <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND Cystic fibrosis" Accession="RCV000007605" Version="32">
        <ClassifiedConditionList TraitSetID="1961">
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2017-03-17" SubmissionCount="10">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND not provided" Accession="RCV000727574" Version="17">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-25" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND not specified" Accession="RCV000781235" Version="9">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND multiple conditions" Accession="RCV001004471" Version="9">
        <ClassifiedConditionList TraitSetID="9641">
          <ClassifiedCondition DB="MedGen" ID="C0403814">Congenital bilateral aplasia of vas deferens from CFTR mutation</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND CFTR-related disorder" Accession="RCV001826442" Version="9">
        <ClassifiedConditionList TraitSetID="52839">
          <ClassifiedCondition>CFTR-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-03-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.3(CFTR):c.2175dup (p.Glu726Argfs) AND Bronchiectasis with or without elevated sweat chloride 1" Accession="RCV003473035" Version="2">
        <ClassifiedConditionList TraitSetID="2434">
          <ClassifiedCondition DB="MedGen" ID="C2749757">Bronchiectasis with or without elevated sweat chloride 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-03-17" NumberOfSubmissions="17" NumberOfSubmitters="16" DateCreated="2017-12-12" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12007216</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15371902</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15371903</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1695717</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18456578</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21474639</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21796730</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22975760</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23765052</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23974870</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32674983</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7686423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7691345</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9150159</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9725922</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://cftr2.org/</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://cftr2.org</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="52839" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42248" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CFTR-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CFTR-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CFTR-related disorder</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CFTR-RD</ElementValue>
              </Symbol>
            </Trait>
          </TraitSet>
          <TraitSet ID="2434" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1065" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cystic Fibrosis-Like Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bronchiectasis with or without elevated sweat chloride 1</ElementValue>
                <XRef ID="MONDO:0008887" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BESC1</ElementValue>
                <XRef Type="MIM" ID="211400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18054" />
                <XRef ID="18054" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="60033" DB="Orphanet" />
              <XRef ID="C2749757" DB="MedGen" />
              <XRef ID="MONDO:0008887" DB="MONDO" />
              <XRef Type="MIM" ID="211400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9641" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
            <Trait ID="3944" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital bilateral aplasia of vas deferens from CFTR mutation</ElementValue>
                <XRef ID="MONDO:0010178" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CBAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAVD</ElementValue>
                <XRef Type="MIM" ID="277180" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15243" />
                <XRef ID="15243" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <XRef ID="48" DB="Orphanet" />
              <XRef ID="C0403814" DB="MedGen" />
              <XRef ID="MONDO:0010178" DB="MONDO" />
              <XRef Type="MIM" ID="277180" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="146873" SubmissionDate="2017-06-29" DateLastUpdated="2017-12-12" DateCreated="2013-10-18">
        <ClinVarSubmissionID localKey="2307insA|Cystic fibrosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000071474" DateUpdated="2017-12-12" DateCreated="2013-10-18" Type="SCV" Version="4" SubmitterName="CFTR2" OrgID="500092" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://cftr2.org</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sosnay PR et al. (Nat Genet 2013)</Attribute>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Glu726ArgfsX4</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <URL>http://cftr2.org</URL>
        </Citation>
        <Citation>
          <URL>https://cftr2.org</URL>
        </Citation>
        <StudyName>CFTR2</StudyName>
        <StudyDescription>Clinical and Functional TRanslation of CFTR</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB2827387</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27806" SubmissionDate="2018-04-09" DateLastUpdated="2018-04-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602421.0081_CYSTIC FIBROSIS" title="CFTR, 1-BP INS, 2307A_CYSTIC FIBROSIS" />
        <ClinVarAccession Accession="SCV000027806" DateUpdated="2018-04-12" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">By chemical mismatch cleavage in an African American patient with cystic fibrosis (CF; 219700), Smit et al. (1993) found homozygosity for insertion of an adenine after nucleotide 2307 in exon 13. The resulting shift of the reading frame at codon 726 introduced 2 consecutive stop codons at amino acid positions 729 and 730. To examine the mRNA level associated with the 2307insA mutation, RNA from nasal epithelial cells of the patient and a normal subject were reverse transcribed. Subsequent amplification of the cDNA demonstrated that the CFTR message level associated with 2307insA was markedly reduced compared to the normal control, while both the patient and the normal subject showed similar levels of expression.</Attribute>
              <Citation>
                <ID Source="PubMed">7686423</ID>
              </Citation>
              <XRef DB="OMIM" ID="219700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <Name>CFTR, 1-BP INS, 2307A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2307A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602421.0081" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CYSTIC FIBROSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292572" SubmissionDate="2019-09-27" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="NC_000007.13:g.117232396dupA|OMIM:277180;219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163516" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117232396dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277180" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2307525" SubmissionDate="2019-09-16" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="c.2175dup|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001169544" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="CFTR-France" OrgID="507119" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Claustres M et al. (Hum Mutat 2017)</Attribute>
          <Citation>
            <ID Source="PubMed">28603918</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">cystic fibrosis</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28603918</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB6300041</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354373" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="255|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001193918" DateUpdated="2020-07-06" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000677922" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000677922 was merged into SCV001193918 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Comment>NM_000492.3(CFTR):c.2175dupA(E726Rfs*4, aka 2307insA) is classified as pathogenic in the context of cystic fibrosis and is associated with the classic form of disease. Sources cited for classification include the following: PMID 23974870. Classification of NM_000492.3(CFTR):c.2175dupA(E726Rfs*4, aka 2307insA) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="GA" referenceAllele="G" start="117232394" stop="117232394" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3375276" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_000492.3:c.2175dupA|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001714843" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://cftr2.org/</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000492.3:exon 14</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Glu726fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108134" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="1199673|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582512" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1695717</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7691345</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9725922</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7686423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15371903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18456578</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7686423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15371903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18456578</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu726Argfs*4) in the CFTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant is present in population databases (rs746418935, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with cystic fibrosis (PMID: 7686423, 15371903, 18456578). It is commonly reported in individuals of African American ancestry (PMID: 7686423, 15371903, 18456578). This variant is also known as c.2307insA. ClinVar contains an entry for this variant (Variation ID: 7185). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117232394_117232395insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056697" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="111716971|Orphanet:ORPHA586" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004847339" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7686423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32674983</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15371903</ID>
          </Citation>
          <Comment>The p.Glu726ArgfsX4 variant in CFTR is commonly reported in individuals of African American ancestry and has been identified in the homozygous or compound heterozygous state with other disease-causing variants in CFTR in at least 2 individuals with clinical features of cystic fibrosis (Smit 1993 PMID: 7686423, Sugarman 2004 PMID: 15371903, Souza 2020 PMID: 32674983). In addition, it has been found in 59 patients in the CFTR2 database, the majority of which are pancreatic insufficient. This variant has also been reported by other clinical laboratories in ClinVar ((Variation ID 7185) and has been identified in 0.02% (9/41432) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). This variant is predicted to cause a frameshift, which alters the proteins amino acid sequence beginning at position 726 and leads to a premature termination codon 4 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the CFTR gene is an established disease mechanism in autosomal recessive cystic fibrosis. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive cystic fibrosis. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000492.4:exon 14</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.117592342_117592343insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA586" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1666729" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="3614_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000854813" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="AA" referenceAllele="A" start="117232396" stop="117232396" variantLength="1" />
            <GeneLocation>NM_000492.3:Ex14</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI931071" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CFTR</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1795761" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-03" DateCreated="2019-06-03">
        <ClinVarSubmissionID localKey="NM_000492.3:c.2175dupA|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000919140" DateUpdated="2019-06-03" DateCreated="2019-06-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23765052</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18456578</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22975760</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15371903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21474639</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15371902</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7686423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21796730</ID>
          </Citation>
          <Comment>Variant summary: CFTR c.2175dupA (p.Glu726ArgfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg., p.Leu732X and p.Arg764X). The variant allele was found at a frequency of 1.9e-05 in 1055458 control chromosomes. This frequency is not higher than expected for a pathogenic variant in CFTR causing Cystic Fibrosis (1.9e-05 vs 0.013), allowing no conclusion about variant significance. c.2175dupA has been reported in the literature as a homozygous and compound heterozygous allele in numerous individuals affected with Cystic Fibrosis. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, which showed &lt;10% of normal CFTR mRNA in patient cells (Smit_1993). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2647004" SubmissionDate="2020-04-20" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="genomeconnect_17393_622|MedGen:C0010674" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001338858" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="GenomeConnect, ClinGen" OrgID="506185" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpretted as Pathogenic and reported on 01-07-2016 by Lab or GTR ID 500068. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Not Provided</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <TypePlatform>Genotyping Panel</TypePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2016-01-07" integerValue="500068">Mayo Clinic Laboratories,Mayo Clinic</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2016-01-26" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormal delivery</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001787" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the umbilical cord</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010881" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Anxiety</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000739" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of cardiovascular system morphology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002564" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormal thrombosis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001977" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of coagulation</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001928" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7304364</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4072831" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000492.4:c.2175dup|CFTR-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002080718" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.2175dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CFTR-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1732867" SubmissionDate="2018-11-11" DateLastUpdated="2022-12-11" DateCreated="2018-04-12">
        <ClinVarSubmissionID localKey="NC_000007.13:g.117232395dupA|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000886215" DateUpdated="2022-12-11" DateCreated="2018-04-12" Type="SCV" Version="2" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117232395dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7530081" SubmissionDate="2023-07-25" DateLastUpdated="2023-11-11" DateCreated="2023-08-19">
        <ClinVarSubmissionID localKey="NM_000492.3:c.2175dup|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004024551" DateUpdated="2023-11-11" DateCreated="2023-08-19" Type="SCV" Version="2" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Disease-causing CFTR variant. See www.CFTR2.org for phenotype information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13708015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8352150" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="3307384|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004563422" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CFTR c.2175dup; p.Glu726ArgfsTer4 variant (rs746418935) is reported in the literature in individuals affected with cystic fibrosis (Smit 1993, Sosnay 2013, Sugarman 2004). This variant is reported in ClinVar (Variation ID: 7185) and is found in the African population with an allele frequency of 0.03% (8/24,954 alleles) in the Genome Aggregation Database. This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Furthermore, in vitro functional assays show a significant reduction in transcript expression (Smit 1993). Based on available information, this variant is considered to be pathogenic. References: Smit LS et al. An African-American cystic fibrosis patient homozygous for a novel frameshift mutation associated with reduced CFTR mRNA levels. Hum Mutat. 1993;2(2):148-51. PMID: 7686423. Sosnay PR et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013 Oct;45(10):1160-7. PMID: 23974870. Sugarman EA et al. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med. 2004 Sep-Oct;6(5):392-9. PMID: 15371903.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117232396dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5214317" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a5692|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002727273" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12007216</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7686423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9150159</ID>
          </Citation>
          <Comment>The c.2175dupA pathogenic mutation, located in coding exon 14 of the CFTR gene, results from a duplication of A at nucleotide position 2175, causing a translational frameshift with a predicted alternate stop codon (p.E726Rfs*4). This mutation was described in the homozygous state in an African American individual with pancreatic insufficient cystic fibrosis, elevated sweat chloride levels, and severe lung disease (Smit LS et al. Hum. Mutat., 1993;2:148-51). The overall frequency of this allele in CF chromosomes has been observed at approximately 0.2%, with the highest occurrence in 2.0% of all African American CF chromosomes (Macek M et al. Am. J. Hum. Genet., 1997 May;60:1122-7; Bobadilla JL et al. Hum. Mutat., 2002 Jun;19:575-606). This pathogenic mutation is associated with elevated sweat chloride levels and pancreatic insufficiency (Sosnay PR et al. Nat. Genet., 2013 Oct;45:1160-7). Of note, this alteration is also known as 2307insA in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.2175dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865942" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000492.4:c.2175dup|OMIM:211400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004213406" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.2175dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4072831" TraitType="Disease" MappingType="Name" MappingValue="CFTR-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="CFTR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108134" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Abnormal thrombosis" MappingRef="Preferred">
        <MedGen CUI="C4025731" Name="Abnormal thrombosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292572" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865942" TraitType="Disease" MappingType="XRef" MappingValue="211400" MappingRef="OMIM">
        <MedGen CUI="C2749757" Name="Bronchiectasis with or without elevated sweat chloride 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1795761" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the umbilical cord" MappingRef="Preferred">
        <MedGen CUI="C0266785" Name="Abnormality of the umbilical cord" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8352150" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of cardiovascular system morphology" MappingRef="Preferred">
        <MedGen CUI="C4049796" Name="Abnormal cardiovascular system morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="146873" TraitType="Disease" MappingType="Name" MappingValue="Cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Abnormal delivery" MappingRef="Preferred">
        <MedGen CUI="C0549629" Name="Abnormal delivery" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292572" TraitType="Disease" MappingType="XRef" MappingValue="277180" MappingRef="OMIM">
        <MedGen CUI="C0403814" Name="Congenital bilateral aplasia of vas deferens from CFTR mutation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7530081" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Anxiety" MappingRef="Preferred">
        <MedGen CUI="C0003467" Name="Anxiety" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27806" TraitType="Disease" MappingType="Name" MappingValue="CYSTIC FIBROSIS" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1666729" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Disease" MappingType="Name" MappingValue="Cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3375276" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354373" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1732867" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056697" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA586" MappingRef="Orphanet">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2647004" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of coagulation" MappingRef="Preferred">
        <MedGen CUI="C1846821" Name="Abnormality of coagulation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5214317" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307525" TraitType="Disease" MappingType="Name" MappingValue="cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2022-01-11">SCV001471906</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="2" DateDeleted="2017-12-11">SCV000074561</Accession>
        <Description>this interpretation was deleted because it was generated with an out-of-date curation method; no clinical information is available to provide a full interpretation of the variant</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

